Ifp Advisors, Inc Intellia Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 1 shares of NTLA stock, worth $10. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$10

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$20.02 - $27.22 $20 - $27	1 New	1 $0
Q2 2023 Aug 04, 2023	BUY	$34.58 - $46.03 $1,210 - $1,611	35 New	35 $1,000
Q4 2022 Feb 07, 2023	SELL	$33.21 - $62.69 $1,660 - $3,134	-50 Reduced 17.99%	228 $6,000
Q2 2022 Sep 06, 2022	BUY	$38.49 - $76.21 $10,700 - $21,186	278 New	278 $22,000
Q2 2022 Aug 12, 2022	SELL	$38.49 - $76.21 $10,700 - $21,186	-278 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$58.27 - $118.99 $14,975 - $30,580	257 Added 1223.81%	278 $20,000
Q4 2021 Jan 12, 2022	BUY	$100.76 - $138.36 $2,115 - $2,905	21 New	21 $3,000
Q3 2021 Oct 06, 2021	SELL	$132.37 - $176.78 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$60.88 - $161.91 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$46.59 - $83.68 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$18.83 - $63.53 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$17.47 - $24.93 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$11.14 - $22.87 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$9.44 - $15.58 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$10.43 - $17.67 $2,242 - $3,799	-215 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$12.79 - $17.62 $12,790 - $17,620	-1,000 Reduced 82.3%	215 $4,000
Q4 2018 Jan 23, 2019	BUY	$11.39 - $27.13 $2,847 - $6,782	250 Added 25.91%	1,215 $16,000
Q3 2018 Oct 25, 2018	SELL	$25.78 - $32.6 $23,588 - $29,829	-915 Reduced 48.67%	965 $0
Q2 2018 Aug 07, 2018	BUY	$20.02 - $30.79 $2,602 - $4,002	130 Added 7.43%	1,880 $0
Q1 2018 Jun 03, 2019	BUY	$19.43 - $34.95 $1,651 - $2,970	85 Added 5.11%	1,750 $34,000
Q1 2018 May 09, 2018	SELL	$19.43 - $34.95 $1,651 - $2,970	-85 Reduced 4.86%	1,665 $0
Q4 2017 Jan 24, 2018	BUY	$17.39 - $31.12 $25,389 - $45,435	1,460 Added 503.45%	1,750 $0
Q3 2017 Oct 30, 2017	BUY	$15.16 - $25.75 $758 - $1,287	50 Added 20.83%	290 $7,000
Q4 2016 Jun 03, 2019	BUY	N/A	25 Added 11.63%	240 $3,000
Q1 2016 Jun 03, 2019	BUY	N/A	215	215 $4,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$125 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$98.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$97.9 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$52.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$50.5 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account